|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Expenses: | |||||
| Consulting (Note 13) | |||||
| Research and development (Note 10) | |||||
| Selling, general and administrative (Notes 9 and 13) | |||||
| Share-based compensation (Notes 7 and 13) | |||||
| Loss from operations | |||||
| Interest income | |||||
| Gain on reduction of commitment to issue shares (Note 6) | |||||
| Net loss | |||||
| Other comprehensive loss | |||||
| Currency translation differences | |||||
| Total comprehensive loss | |||||
| Net loss per share – basic and diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding – basic and diluted (in shares) | |||||
Loading...